Amgen (AMGN) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$8.4B
Revenue reported for this quarter.
Quarter-over-quarter
+12.6%
Change from the immediately preceding quarter.
Year-over-year
+20.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$30.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $6.9B | +3.8% |
| Dec 31, 2023 | $8.2B | +19.8% |
| Mar 31, 2024 | $7.4B | +22.0% |
| Jun 30, 2024 | $8.4B | +20.1% |
Revenue performance
The reported revenue reflects a positive direction, with the latest quarter surpassing the level of the prior period.
Quarterly comparison
Sequentially, revenue rose from the prior quarter. On a year-over-year basis, revenue also grew compared to the same quarter a year ago.
What to watch
Uncertain macroeconomic conditions, including inflation and higher interest rates, are highlighted in the filing as factors to monitor.